[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-361192-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-361192-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","evaluation-of-punicalagin-as-a-multi-targeted-therapeutic-agent-against-endometrial-cancer","Evaluation of Punicalagin as a multi-targeted therapeutic agent against endometrial cancer","","Endometrial cancer (EC) is an increasing clinical concern, with limited treatment options for advanced or recurrent disease. This study evaluated punicalagin (PCG), a natural pomegranate ellagitannin polyphenol, using in vitro and in vivo EC models. In EC cell lines Ishikawa and SNU-539, PCG suppressed cell proliferation and colony formation in a dose-dependent manner, inhibited migration, and increased E-cadherin. Mechanistic data showed reduced mitochondrial membrane potential, elevated reactive oxygen species, apoptosis with increased BAX and Hoechst/PI positivity, and autophagy marked by LC3-II levels and autophagic vacuoles. In a xenograft mouse model, PCG significantly reduced tumor volume and weight without notable body-weight effects, indicating strong anticancer efficacy with low toxicity.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/evaluation-of-punicalagin-as-a-multi-targeted-therapeutic-agent-against-endometrial-cancer/361192/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/evaluation-of-punicalagin-as-a-multi-targeted-therapeutic-agent-against-endometrial-cancer/361192.png","ImageObject",300,407,{"name":42,"@type":43},"PakDamar76","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What cancer type and compound were evaluated in the study?","Question",{"text":63,"@type":64},"The study focused on endometrial cancer and evaluated punicalagin (PCG), a natural ellagitannin polyphenol from pomegranate.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did punicalagin affect endometrial cancer cell behaviors in vitro?",{"text":68,"@type":64},"PCG inhibited proliferation and colony formation in a dose-dependent manner, reduced Transwell migration, and increased E-cadherin expression, consistent with inhibition of epithelial-mesenchymal transition.",{"name":70,"@type":61,"acceptedAnswer":71},"What mechanisms and in vivo outcomes were reported for PCG?",{"text":72,"@type":64},"PCG decreased mitochondrial membrane potential, increased reactive oxygen species, and induced apoptosis (including higher BAX and Hoechst/PI staining). It also showed signs of autophagy (LC3-IIB and autophagic vacuoles). In xenograft mice, PCG significantly reduced tumor volume and weight with no significant body-weight change.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},361192,1791070462,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},962090893057,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","INTERNATIONAL JOURNAL OF ONCOLOGY 69: 109, 2026  \nEvaluation of Punicalagin as a multi‑targeted therapeutic agent against endometrial cancer  \nZEESHAN AHMAD BHUTTA 1,2* , DOHEE AHN 1* , HONG KYU LEE3 and KYUNG‑CHUL CHOI 1  \n1  \nLaboratory of Biochemistry and Immunology, College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungcheongbuk 28644, Republic of Korea; 2State Key Laboratory of Molecular Vaccinology and Molecular, Diagnostics and Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, Fujian 361002, P.R. China; 3Department of Companion Animal Health, College of Biomedical Science and Health, Inje University, Gyeongsangnam 50834, Republic of Korea  \nReceived December 22, 2025; Accepted July 1, 2026  \nDOI: 10.3892/ijo.2026.5922  \nAbstract. Endometrial cancer (EC) has become an increasing clinical concern as the incidence is rising, and treatment options available for advanced disease or recur‑ rent disease are limited. In the present study, the anticancer potential of punicalagin (PCG), a natural ellagitannin poly‑ phenol that comes from pomegranate, was characterized using both in vitro and in vivo models in EC. Two EC cell lines (Ishikawa and SNU‑539) treated with increasing doses of PCG showed dose‑dependent inhibition of cell prolifera‑ tion and demonstrated a decrease in colony formation. PCG inhibited Transwell migration and an increase in E‑cadherin expression, indicating an inhibition of epithelial‑mesen‑ chymal transition. Further experimental work characterized the mechanisms by which PCG acted and revealed that it decreased the mitochondrial membrane potential and subse‑ quently increased levels of reactive oxygen species, which led to apoptosis as shown by increased BAX expression and Hoechst/PI staining. In addition, PCG showed signs of autophagy, especially in the Ishikawa cells, as indicated by increased levels of LC3‑IIB and the formation of autophagic vacuoles . In vivo studies using a xenograft mouse model showed that treatment with PCG significantly reduced  \nCorrespondence to: Professor Kyung‑Chul Choi, Laboratory of Biochemistry and Immunology, College of Veterinary Medicine, Chungbuk National University, 1 Chungdae, Seowon, Cheongju, Chungcheongbuk 28644, Republic of Korea  \nE‑[mail: kchoi@cbu.ac.kr](mail: kchoi@cbu.ac.kr)  \nDr Hong Kyu Lee, Department of Companion Animal Health, College of Biomedical Science and Health, Inje University, 197 Inje, Gimhae, Gyeongsangnam 50834, Republic of Korea  \nE‑[mail: hklee83@inje.ac.kr](mail: hklee83@inje.ac.kr)[ ](mail: hklee83@inje.ac.kr)*Contributed equally  \nKey words: endometrial cancer, carcinoma, apoptosis, autophagy, punicalagin  \ntumor volume and weight, whereas body weight was not significantly affected, thus highlighting strong anticancer efficacy coupled with very low toxicity. Overall, the present study highlights PCG as a promising natural compound with multitarget anticancer activity against EC and warrants further preclinical and clinical research as a potential treatment option.  \nIntroduction  \nEndometrial cancer (EC) is a major global health issue, with~420,368 new cases diagnosed globally as of 2022 (1,2) . The American Cancer Society reports ~68,270 new cases of uterine cancer will be diagnosed in 2026, resulting in~14,450 expected deaths due to uterine cancers (3) . The inci‑ dence of EC has increased by more than 1% per year since the mid‑2000s, particularly among non‑White racial and ethnic women (4,5) .  \nThe etiology of EC involves a complicated spectrum of molecular biology, including oncogenic mutations in tumor suppressor genes (PTEN, TP53 and ARID1A), activation of oncogenes (KRAS, CTNNB1 and HER2/neu), defects in DNA mismatch repair pathways, aberrations in hormonal signaling, epigenetic changes and dysregulated angiogenesis (6) . The Cancer Genome Atlas (TCGA) identifies four molecular subtypes of ECs characterized by POLE ultra‑mutated, micro‑ satellite inst","cbCaivKbeAR9HTsT","https://ap.wps.com/l/cbCaivKbeAR9HTsT","pdf",4459665,14,"English","# Abstract\n# Introduction\n## Epidemiology and molecular background\n## Current treatment landscape and unmet needs\n## Rationale for natural compounds and PCG","[{\"question\":\"What cancer type and compound were evaluated in the study?\",\"answer\":\"The study focused on endometrial cancer and evaluated punicalagin (PCG), a natural ellagitannin polyphenol from pomegranate.\"},{\"question\":\"How did punicalagin affect endometrial cancer cell behaviors in vitro?\",\"answer\":\"PCG inhibited proliferation and colony formation in a dose-dependent manner, reduced Transwell migration, and increased E-cadherin expression, consistent with inhibition of epithelial-mesenchymal transition.\"},{\"question\":\"What mechanisms and in vivo outcomes were reported for PCG?\",\"answer\":\"PCG decreased mitochondrial membrane potential, increased reactive oxygen species, and induced apoptosis (including higher BAX and Hoechst/PI staining). It also showed signs of autophagy (LC3-IIB and autophagic vacuoles). In xenograft mice, PCG significantly reduced tumor volume and weight with no significant body-weight change.\"}]","Evaluation of Punicalagin as a multi-targeted therapeutic agent against endometrial cancer | PDF",1790143476,35,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2c49a7bac681ec3c78a3eaaea50576e4.webp",983,1357,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/93f67ee3f5d0410faadfb10ce1b912bb.webp",982,1356,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fa68149c27bcce2ad7cac5a4d2a34392.webp",981,1354,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dd9c64e4807d06234e83b715b5e9423a.webp",980,1353]